Alex Thompson

Stock Analyst at Stifel

(0)
# 4903
Out of 5,329 analysts
43
Total ratings
27.78%
Success rate
-28.51%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
TVTX Travere Therapeutics
Maintains: Hold
22 23
20.59 11.7% 3 May 2, 2025
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.17 -3.29% 2 Mar 28, 2025
AVTX Avalo Therapeutics
Initiates Coverage On: Buy
36
5.16 597.67% 1 Mar 25, 2025
CRNX Crinetics Pharmaceut...
Initiates Coverage On: Buy
60
34.25 75.18% 1 Mar 25, 2025
ASND Ascendis Pharma
Maintains: Strong Buy
200 207
172.85 19.76% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
651.41 -23.24% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
15.32 252.48% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
21.83 101.56% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
1.39 43.88% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
42.01 64.25% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.39 -28.06% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
13.66 192.83% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
0.95 4110.53% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
16.19 110.01% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.66 1887.95% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022